Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis
| Autor: | Tawseef Dar, Andrea Natale, Luigi Di Biase, Jalaj Garg, Venkat Vuddanda, Mohit K. Turagam, Bharath Yarlagadda, Arash Aryana, Scott Koerber, Dhanunjaya Lakkireddy |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Catheter ablation 030204 cardiovascular system & hematology Ventricular tachycardia law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Physiology (medical) Internal medicine medicine Humans 030212 general & internal medicine Impella Ejection fraction business.industry medicine.disease Confidence interval Ventricular assist device Relative risk Catheter Ablation Tachycardia Ventricular Cardiology Heart-Assist Devices Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of Interventional Cardiac Electrophysiology. 55:197-205 |
| ISSN: | 1572-8595 1383-875X |
| DOI: | 10.1007/s10840-018-0477-1 |
| Popis: | There is a lack of compelling data regarding the benefit of percutaneous ventricular assist devices (PVAD) in patients undergoing ventricular tachycardia (VT) ablation. The study aims to conduct a meta-analysis comparing the safety and efficacy of PVAD versus no-PVAD (N-PVAD) during VT ablation. Studies meeting criteria were systematically reviewed. Baseline characteristics and clinical outcomes were extracted and analyzed. A meta-analysis was performed using random-effects model to calculate risk ratio (RR) and mean difference (MD) with 95% confidence interval (CI). The meta-analysis included five retrospective, observational studies consisting of 2026 patients (PVAD group—284 patients versus N-PVAD group—1742 patients). The PVAD group was sicker with significantly higher VT storm, lower LVEF and greater proportion of NYHA class ≥ III than N-PVAD (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink